(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 17.47% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.29%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Evolent Health's revenue in 2024 is $1,963,896,000.On average, 5 Wall Street analysts forecast EVH's revenue for 2024 to be $283,663,485,587, with the lowest EVH revenue forecast at $280,286,231,516, and the highest EVH revenue forecast at $285,467,889,020. On average, 5 Wall Street analysts forecast EVH's revenue for 2025 to be $327,244,699,635, with the lowest EVH revenue forecast at $312,088,380,296, and the highest EVH revenue forecast at $341,621,865,752.
In 2026, EVH is forecast to generate $366,306,594,134 in revenue, with the lowest revenue forecast at $339,537,659,741 and the highest revenue forecast at $388,617,386,936.